Zhejiang Jingxin Pharmaceutical Co., Ltd. ( China (Mainland))

Jingxin Pharm, established in 1990, is one of the Top 100 companies in the Chinese pharmaceutical industry. Jingxin Pharm has Chinese GMP, ISO14001 approvals, KFDA approvals and Germany GMP approvals for Finished Dosage forms and APIs’ facility.

Jingxin Pharm sells APIs, finished dosage forms and chinese herbal drugs mainly manufacturing quinolone antibiotics and cardiovascular drugs. Some APIs include Ofloxacin (82419-36-1), Enrofloxacin HCL (112732-17-9), Enrofloxacin Base (93106-60-6), Simvastatin (79902-63-9), Loratadine (79794-75-5), etc.

Jingxin Pharm has two manufacturing sites for APIs (at Guangfeng in Jiangxi Province and at Shangyu near Hangzhou in Zhejiang Province) and two manufacturing sites for Dosage forms (at Xinchang near Hangzhou and in Inner Mongolia) along with capacity of 1.2 billion Tablets & Capsules per year. Jingxin Pharm has two R&D centre (at Xinchang near Hangzhou and Zhangjiang in Shanghai).